International Stem Cell delays Q3 report over discontinued operations accounting
ISCO•International Stem Cell delayed its Form 10-Q for the quarter ended September 30, 2026, because the third-quarter sale of Lifeline Cell Technology requires discontinued operations accounting and recasting prior-period financial statements. The company expects to file within five calendar days of the deadline and anticipates no significant year-over-year change in operating results.
1. Filing delay
International Stem Cell delayed its Form 10-Q for the quarter ended September 30, 2026, primarily because the third-quarter sale of Lifeline Cell Technology requires discontinued operations accounting, including recasting prior-period financial statements. The company expects to file within five calendar days of the prescribed deadline and anticipates no significant year-over-year change in operating results.




